NCT04351737View on ClinicalTrials.gov

Dextenza for Post-operative Treatment of Pterygium

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 15, 2020

Primary Completion Date

July 15, 2022

Study Completion Date

May 23, 2023

Conditions
Pterygium of Both Eyes
Interventions
DRUG

Intracanalicular Dexamethasone, (0.4 mg) Insert

To determine post-surgical resolution of pain and inflammation outcomes with DEXTENZA compared to topical steroid treatment in patients who undergo bilateral pterygium surgery.

DRUG

Prednisolone Acetate

To reduce post-surgical pain and inflammation in patients who undergo bilateral pterygium surgery.

Trial Locations (1)

33511

Brandon Eye Associates, Brandon

All Listed Sponsors
lead

Brandon Eye Associates, PA

OTHER

NCT04351737 - Dextenza for Post-operative Treatment of Pterygium | Biotech Hunter | Biotech Hunter